P/S ratio for Concert Pharmaceuticals (CNCE)

P/S ratio on May 5, 2023 (TTM) : > 1000

According to Concert Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.02. At the end of 2022 the company had a P/S ratio of > 1000.

P/S ratio history for Concert Pharmaceuticals from 2014 to 2022

PS ratio at the end of each year

Year	P/S ratio	Change
2022	> 1000	228072.18%
2021	3.35	-93.42%
2020	51.0	-75.07%
2019	204	630.05%
2018	28.0	583.89%
2017	4.09	-99.69%
2016	> 1000	20804.8%
2015	6.30	-77.75%
2014	28.3

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
AbbVie ABBV	5.57	-99.94%	🇺🇸 USA
Ardelyx ARDX	5.86	-99.94%	🇺🇸 USA
Jazz Pharmaceuticals JAZZ	1.86	-99.98%	🇮🇪 Ireland
Trevena TRVN	1.97	-99.98%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions